Seeing Is Believing
Currently out of the existing stock ratings of Eric Joseph, 121 are a BUY (54.02%), 85 are a HOLD (37.95%), 18 are a SELL (8.04%).
Analyst Eric Joseph, currently employed at JPMORGAN, carries an average stock price target met ratio of 61.59% that have a potential upside of 43.99% achieved within 185 days.
Eric Joseph’s has documented 427 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on RXRX, Recursion Pharmaceuticals at 17-Dec-2025.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for MNTA (MOMENTA PHARMACEUTICALS) at 1/14/2020. The price target of $30 was fulfilled within 2 days with a profit of $4.64 (18.3%) receiving and performance score of 91.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Aug-2023
$7.5
$6.14 (451.47%)
$7.5
9 months 26 days ago
(04-Apr-2025)
14/29 (48.28%)
$5.73 (323.73%)
327
Buy Since 31-May-2023
$4
$2.64 (194.12%)
$2
2 years 7 months 30 days ago
(31-May-2023)
2/12 (16.67%)
$2.96 (284.62%)
753
Buy Since 08-Mar-2021
$1
$-0.36 (-26.47%)
$8
3 years 9 months 29 days ago
(01-Apr-2022)
1/2 (50%)
$0.33 (49.25%)
311
Buy
$7
3 years 9 months 30 days ago
(31-Mar-2022)
3/6 (50%)
$5.37 (107.92%)
411
Hold Since 31-Mar-2022
$2
$0.64 (47.06%)
$6
3 years 9 months 30 days ago
(31-Mar-2022)
3/11 (27.27%)
$1.28 (177.78%)
467
Which stock is Eric Joseph is most bullish on?
Which stock is Eric Joseph is most reserved on?
What Year was the first public recommendation made by Eric Joseph?